252) ed experience in designing and conducting clinical trials, and creation of internati |
253) In many clinical trials, baseline covariates could |
254) s technology has already been employed in clinical trials, confirming the safety and |
255) requires confirmatory findings from large clinical trials, emerging evidence indicat |
256) ct approaches are now being considered in clinical trials, such as double-UCB transp |
257) or structure found in this study may have clinical utility and merits further invest |
258) implications for the generalizability and clinical utility of TBI clusters. |
259) esult in biased conclusions regarding the clinical utility of new biomarkers. |
260) developed by Fan and colleagues may be of clinical utility to assess cognitive funct |
261) ibition of these enzymes has proved great clinical utility. |
262) sion on protein level was correlated with clinical characteristics and impact on sur |
263) udies of EBTs matched the demographic and clinical characteristics of nearly as many |
264) was to evaluate the clinic prevalence and clinical characteristics of patients with |
265) stem but suggest that the demographic and clinical characteristics of the population |
266) Clinical evaluation included pocket depth, |
267) Our findings suggest that clinical evaluation of aqueous flare is su |
268) Sterility measures were applied for clinical evaluation. |
269) tiating cells and the benefit for further clinical evaluation. |
270) ve to pathobiological modeling as well as clinical management for oral mucositis cau |
271) The daily clinical management has benefited by the i |
272) s well-tolerated and may be useful in the clinical management of bone-invasive felin |
273) e subsequent physiologic consequences and clinical management. |
274) rt of embryos on day 3 resulted in better clinical outcomes compared with cryopreser |
275) nuary and 31 December of 2010 to evaluate clinical outcomes that occur when a new In |
276) veness of various debridement methods and clinical outcomes to help inform clinician |
277) king and impulsivity may markedly improve clinical outcomes. |
278) in disease (LSD) in Jordan and associated clinical signs, complications and prelimin |
279) Signalment, type and duration of clinical signs, metastasis site, pathology |
280) ient animals by monitoring development of clinical signs, testing of blood for the p |
281) ion and decreased body weight were common clinical signs, while mastitis and myiasis |
282) bleeding on probing, probing depth (PD), clinical attachment level (CAL), and gingi |
283) Probing depth, clinical attachment level, and keratinized |
284) idual pockets (pocket depth (PD) ≥5 mm, clinical attachment loss ≥2 mm, and blee |
|